IMMUNOGLOBULIN A NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to protect kidneys from scarring disease
Disease control CompletedThis study tested whether adding the drug atrasentan helps control IgA nephropathy, a kidney disease that causes scarring, in patients already taking standard protective medications. Fifty-four adults with the disease tried atrasentan and a placebo in different orders to see whic…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug combo shows promise for slowing kidney disease
Disease control CompletedThis study tested whether adding a new medication called sparsentan could help adults with IgA nephropathy (IgAN), a kidney disease, when they were already taking standard treatments. Researchers followed 48 participants for 28 weeks to see if the combination was safe and could r…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC